162 related articles for article (PubMed ID: 22086127)
1. Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
Yang J; Xiao Z; Li T; Gu X; Fan B
Int J Oncol; 2012 Apr; 40(4):1230-7. PubMed ID: 22086127
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.
Okazaki T; Ebihara S; Asada M; Yamanda S; Niu K; Arai H
Neoplasia; 2008 Sep; 10(9):932-9. PubMed ID: 18714393
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
[TBL] [Abstract][Full Text] [Related]
4. Epo is involved in angiogenesis in human glioma.
Nico B; Annese T; Guidolin D; Finato N; Crivellato E; Ribatti D
J Neurooncol; 2011 Mar; 102(1):51-8. PubMed ID: 20614229
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis.
Yan F; Zhang M; Meng Y; Li H; Yu L; Fu X; Tang Y; Jiang C
Brain Res; 2016 Nov; 1651():104-113. PubMed ID: 27659964
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
Miyake M; Goodison S; Lawton A; Zhang G; Gomes-Giacoia E; Rosser CJ
J Hematol Oncol; 2013 Sep; 6():65. PubMed ID: 24004818
[TBL] [Abstract][Full Text] [Related]
7. TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas.
Xiao Z; Liu Q; Mao F; Wu J; Lei T
Int J Mol Sci; 2011; 12(6):4165-79. PubMed ID: 21747731
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.
Wang L; Zhang Z; Wang Y; Zhang R; Chopp M
Stroke; 2004 Jul; 35(7):1732-7. PubMed ID: 15178821
[TBL] [Abstract][Full Text] [Related]
9. Effects and mechanism of recombinant human erythropoietin on the growth of human breast cancer MDA-MB-231 cells in nude mice.
Jin W; Lin Z; Zhang X; Kong L; Yang L
Pathol Res Pract; 2015 Aug; 211(8):570-6. PubMed ID: 26008780
[TBL] [Abstract][Full Text] [Related]
10. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
11. Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO.
Bader A; Ebert S; Giri S; Kremer M; Liu S; Nerlich A; Günter CI; Smith DU; Machens HG
Int J Nanomedicine; 2012; 7():1227-37. PubMed ID: 22419870
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α primes cerebral endothelial cells for erythropoietin-induced angiogenesis.
Wang L; Chopp M; Teng H; Bolz M; Francisco MA; Aluigi DM; Wang XL; Zhang RL; Chrsitensen S; Sager TN; Szalad A; Zhang ZG
J Cereb Blood Flow Metab; 2011 Feb; 31(2):640-7. PubMed ID: 20700128
[TBL] [Abstract][Full Text] [Related]
14. The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats.
Zhao J; Li G; Zhang Y; Su X; Hang C
Cytokine; 2011 Nov; 56(2):343-50. PubMed ID: 21843949
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
[TBL] [Abstract][Full Text] [Related]
18. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
[TBL] [Abstract][Full Text] [Related]
19. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
